The future of managed care organization

被引:27
|
作者
Robinson, JC
机构
关键词
D O I
10.1377/hlthaff.18.2.7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This paper analyzes the transformation of the central organization in the managed care system: the multiproduct, multimarket health plan. It examines vertical disintegration, the shift from ownership to contractual linkages between plans and provider organizations, and horizontal integration-the consolidation of erstwhile indemnity carriers, Blue Cross plans, health maintenance organizations (HMOs), and specialty networks. Health care consumers differ widely in their preferences and willingness to pay for particular products and network characteristics, while providers differ widely in their willingness to adopt particular organizational and financing structures. This heterogeneity creates an enduring role for health plans that are diversified into multiple networks, benefit products, distribution channels, and geographic regions. Diversification now is driving health plans toward being national, full-service corporations and away from being local, single-product organizations linked to particular providers and selling to particular consumer niches.
引用
收藏
页码:7 / 24
页数:18
相关论文
共 50 条
  • [41] The costs of vascular dementia in a Medicare managed care organization
    Hill, J
    Sadik, K
    Futterman, R
    Fillit, H
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S55 - S56
  • [42] Validation of a Neighborhood SES Index in a Managed Care Organization
    Roblin, Douglas W.
    [J]. MEDICAL CARE, 2013, 51 (01) : E1 - E8
  • [43] ASSOCIATION OF MANAGED CARE ORGANIZATION HCBS QUALITY AND HEALTH CARE UTILIZATION
    Jutkowitz, Eric
    Mulcahy, John
    Huckfeldt, Peter
    Frenier, Christopher
    Shippee, Tetyana
    [J]. INNOVATION IN AGING, 2023, 7 : 245 - 246
  • [44] The clinical guideline process within a managed care organization
    Richman, R
    Lancaster, DR
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (04) : 1061 - 1076
  • [45] The budget impact of tegaserod on a managed care organization formulary
    Bloom, MA
    Barghout, V
    Kahler, KH
    Bentkover, JD
    Kurth, H
    Gralnek, IM
    Spiegel, B
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 370 - 370
  • [46] Safety of Zostavax™-A cohort study in a managed care organization
    Baxter, Roger
    Trung Nam Tran
    Hansen, John
    Emery, Michael
    Fireman, Bruce
    Bartlett, Joan
    Lewis, Ned
    Saddier, Patricia
    [J]. VACCINE, 2012, 30 (47) : 6636 - 6641
  • [47] Budget impact of tegaserod on a managed care organization formulary
    Bloom, MA
    Barghout, V
    Kahler, KH
    Bentkover, J
    Kurth, H
    Gralnek, IM
    Spiegel, BMR
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (01): : S27 - S34
  • [48] Primary Nonadherence to Statin Medications in a Managed Care Organization
    Cheetham, T. Craig
    Niu, Fang
    Green, Kelley
    Scott, Ronald D.
    Derose, Stephen F.
    Vansomphone, Southida S.
    Shin, Janet
    Tunceli, Kaan
    Reynolds, Kristi
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (05): : 367 - 373
  • [49] CHRONIC COUGH IN ADULTS IN A LARGE MANAGED CARE ORGANIZATION
    Zeiger, Robert
    Schatz, Michael
    Butler, Rebecca
    Weaver, Jessica
    Chen, Wansu
    [J]. CHEST, 2019, 156 (04) : 1686A - 1687A
  • [50] Bipolar disorder: Healthcare utilization in a managed care organization
    Knoth, R
    Chen, K
    Tafesse, E
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S151 - S151